SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
20053325
Source:
http://linkedlifedata.com/resource/pubmed/id/20053325
Search
Subject
(
59
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0004448
,
umls-concept:C0006823
,
umls-concept:C0009429
,
umls-concept:C0033860
,
umls-concept:C0087111
,
umls-concept:C0449774
,
umls-concept:C0556895
,
umls-concept:C0962603
,
umls-concept:C2603343
pubmed:dateCreated
2010-1-7
pubmed:abstractText
Evidence from clinical trials supports the use of alefacept for the treatment of patients with chronic plaque psoriasis, either as monotherapy or combined with other treatment modalities.
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/9614685
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Dermatologic Agents
,
http://linkedlifedata.com/resource/pubmed/chemical/Immunosuppressive Agents
,
http://linkedlifedata.com/resource/pubmed/chemical/Recombinant Fusion Proteins
,
http://linkedlifedata.com/resource/pubmed/chemical/alefacept
pubmed:status
MEDLINE
pubmed:month
Dec
pubmed:issn
1203-4754
pubmed:author
pubmed-author:BissonnetteRobertR
,
pubmed-author:LandellsIanI
,
pubmed-author:LuiHarveyH
,
pubmed-author:PappKimK
,
pubmed-author:SearlesGordonG
,
pubmed-author:ShearNeil HNH
pubmed:issnType
Print
pubmed:volume
13 Suppl 3
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
S131-8
pubmed:meshHeading
pubmed-meshheading:20053325-Adolescent
,
pubmed-meshheading:20053325-Adult
,
pubmed-meshheading:20053325-Canada
,
pubmed-meshheading:20053325-Dermatologic Agents
,
pubmed-meshheading:20053325-Dose-Response Relationship, Drug
,
pubmed-meshheading:20053325-Drug Administration Routes
,
pubmed-meshheading:20053325-Drug Therapy, Combination
,
pubmed-meshheading:20053325-Follow-Up Studies
,
pubmed-meshheading:20053325-Humans
,
pubmed-meshheading:20053325-Immunosuppressive Agents
,
pubmed-meshheading:20053325-Morbidity
,
pubmed-meshheading:20053325-Prospective Studies
,
pubmed-meshheading:20053325-Psoriasis
,
pubmed-meshheading:20053325-Recombinant Fusion Proteins
,
pubmed-meshheading:20053325-Time Factors
,
pubmed-meshheading:20053325-Treatment Outcome
,
pubmed-meshheading:20053325-Young Adult
pubmed:year
2009
pubmed:articleTitle
Patterns of combination therapy with alefacept for the treatment of psoriasis in Canada in the AWARE study.
pubmed:affiliation
Keystone Dermatology Institute, Edmonton, AB. gesearles@mac.com
pubmed:publicationType
Journal Article
,
Comparative Study
,
Randomized Controlled Trial
,
Research Support, Non-U.S. Gov't
,
Multicenter Study
,
Clinical Trial, Phase IV